Bristol Myers Squibb (BMS), a global biopharmaceutical leader, recently celebrated its 60th anniversary in Singapore by ...
Lotus Pharmaceutical, a global pharmaceutical company headquartered in Taiwan, has announced that its wholly owned subsi...
Japan-based Tanabe Pharma has decided to transfer the domestic manufacturing and marketing approvals, manufacturing and ...
ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...
University College London (UCL) and Japanese pharma firm Eisai have signed a new agreement to extend their long-standing...
Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals has entered into a co-development and...
China-based Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have jointly announced the offi...
The Faculty of Pharmacy, Mahidol University (MUPY), Thailand, has signed a Memorandum of Understanding (MoU) with We-Win...
Cadila Pharmaceuticals, one of India’s leading integrated pharmaceutical companies, and Wellesta Holdings, Singapo...
Arcera Life Sciences, a global life sciences company focused on advancing innovative and sustainable healthcare solution...
Eli Lilly Drugstore LLC (Lilly) and the Department of Health – Abu Dhabi (DoH), regulator of the healthcare sector...
Since the expansion, the Peenya facility has evolved into a key hub for Merck KGaA—what would you consider its mos...
The rapid growth of biologics and advanced therapies is placing new demands on supply chains, exposing infrastructure ga...
Zydus Lifesciences and Sunshine Healthcare have announced the setting up of a strategic joint venture (JV) company &ndas...
CStone Pharmaceuticals, a China-based biopharmaceutical company, has entered into an exclusive commercialisation agreeme...
Japan-based Nippon Shinyaku has entered into an option agreement with US-based Elixirgen Therapeutics, Inc. under which ...
Mubadala Bio has announced the signing of a licencing and supply agreement with Biosidus, a leading biotechnology compan...
CeleCor Therapeutics has completed submission of its New Drug Application to the U.S. FDA for zalunfiban, its investigat...
As biotech innovation accelerates, Asia emerges as an increasingly important hub, driv...
Cincinnati's life sciences ecosystem is gaining momentum through a unique combination of scientific excellence, collabor...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Ella Woger-Nie...
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with U.S.-based biotechnology company Nuve...
The Department of Health – Abu Dhabi and Biocom California have announced a strategic partnership to create a form...
Cancer drug discovery is entering a more disciplined era. Investors, partners, and clinicians are increasingly focused o...
